November 2017

Financial Chronicle – Crusader for Affordable Healthcare

July 2017

The Live Mint – It’s Biocon’s day in the sun

Economic Times – US FDA Panel Nod for Biocon Breast Cancer Drug Biosimilar

May 2017

The Times of India – US institute honours Kiran with award for excellence

The Business Standard – ‘We need a system which provides quality drugs at low cost’ Interview with Ms. Shaw

April 2017

Business Standard – Biocon Q4 profits up 75% to Rs 135-Cr

Times of India – Biocon set to issue bonus shares 2:1; revenue flat in Q4

March 2017

The Hindu Business Line – Our biologics business is expected to  continue on its strong growth trajectory

Business Standard – For Biocon, Windfall seen from drug launch

Bloomberg International – Biocon’s strong positioning in the area of Biosimilars and robust pipeline.

Corporate Citizen – Healing The World

February 2017

The Financial Express – USFDA accepts Biocon’s drug application for review

The Live Mint – We expect Malaysia unit to break even next  year

January 2017

The Financial Express – Biocon Limited: Strong quarter, positive trends

Economic Times – Tech based patient tracking to make its debut in state

ET Health World – Biocon aims for the highest quality in the lowest cost

The Live Mint – Biocon Q3: All eyes on pot at the end of rainbow

The Live Mint – ‘We expect a turnaround in branded  formulations in FY18’

The Hindu Business Line – Biocon bags Rs 460-cr contract from Malaysia

Business Standard – In Biocon, investors sees a blockbuster pipeline

The Financial Express – Biocon a leading Indian play on global biosimilar scene

The Live Mint – Market opportunity for trastuzumab is $7 billion

Economic Times – Biocon has little room to slip up after strong 2016

The Times of India – These graduates aim to take Biotech to another level